Escalon Medical Corp. (ESMC)
OTCMKTS · Delayed Price · Currency is USD
0.1689
+0.0144 (9.36%)
At close: Dec 19, 2025
Escalon Medical Revenue
Escalon Medical had revenue of $2.68M in the quarter ending September 30, 2025, a decrease of -3.81%. This brings the company's revenue in the last twelve months to $11.94M, up 1.03% year-over-year. In the fiscal year ending June 30, 2025, Escalon Medical had annual revenue of $12.05M with 0.54% growth.
Revenue (ttm)
11.94M
Revenue Growth
+1.03%
P/S Ratio
0.10
Revenue / Employee
306.16K
Employees
39
Market Cap
1.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 12.05M | 64.64K | 0.54% |
| Jun 30, 2024 | 11.98M | -198.71K | -1.63% |
| Jun 30, 2023 | 12.18M | 1.48M | 13.80% |
| Jun 30, 2022 | 10.70M | 231.45K | 2.21% |
| Jun 30, 2021 | 10.47M | 1.07M | 11.40% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Tian'an Technology Group | 2.12M |
| Northwest Biotherapeutics | 937.00K |